Plan ahead

Plan ahead of these events, and schedule time with us!

We can help you:


Understand the landscape in seconds for the targeted therapy of your choice.

Book a demo

To book a live demo to show you how this works specifically to your questions.

Events Beacon will be attending

7th International Neoantigen Summit 2024

April 29 – May 1, 2024 | Amsterdam, Netherlands

Building upon the momentum and progress in the field, such as the announcement of the first British patient to be receiving mRNA-based cancer therapy, the 7th International Neoantigen Summit 2024 returns to Amsterdam to unite the international neoantigen community to overcome neoantigen identificationprediction, and translational challenges that are holding back the full potential of this class of therapies.

Join leading neoantigen trailblazers from the likes of Gritstone BioCureVacMedigeneGeneos Therapeutics Nykode Therapeutics at the only end-to-end, industry-dedicated neoantigen meeting covering the depth and breadth of the field from mRNA- to DNA- and viral vector-based vaccines as well as novel cell therapies with the true potentials to develop safe, durable and effective off-the-shelf or individualized neoantigen immunotherapeutics and vaccines for cancer patients.

Our expert team will be in attendance so make sure to book ahead of time to speak with Jacob Pacey about the evolving landscape and its promising future!

Find out more

3rd Annual LNP Formulation & Process Development Summit

April 29 – May 2, 2024 | Boston, MA

Join the ever-growing community of LNP pioneers as they tackle the challenges associated with developing safe, compliant and efficacious LNPs. This starts with the in vitro discovery of LNPs through to the manufacturing processes, with end-to-end synergy fundamental.

Hear from returning industry powerhouses including Pfizer, Moderna and Alnylam alongside new companies to share their insights to this community such as Capstan Therapeutics, AbbVie, Mana Bio, Serina Therapeutics, Karma Biotechnologies and more.

With an expanded content offering a 3-track and 4-day summit format, we continue to be the most comprehensive, premium LNP content available to industry.

Find out more

5th Cytokine-Based Drug Development Summit 2024

May 21 – 23, 2024 | Boston, MA

As we enter a new era for cytokine therapies, armed with more cutting-edge technologies than ever before and enhanced translational understandings, the field is re-energizing the cytokine space to bring more life-changing drugs to patients.

Curating learnings from previous experiences, the 5th Cytokine-Based Drug Development Summit returns as the only industry-dedicated cytokine meeting with a disease-agnostic approach.

This year, our Research Analyst, Fatima Hayat, joins the expert speaker faculty to explore the cytokine therapeutics landscape to consider ‘Where Are We Now?’ Access the full presentation details here and join us as we open Day 1!

Find out more

6th Treg Directed Therapies Summit 2024

May 21 – 23, 2024 | Boston, MA

Returning to Boston for its 6th year, the Treg-Directed Therapies Summit stands as the singular industry forum shining a spotlight on the groundbreaking research and clinical advancements in CAR-Treg and IL2 mutein therapies.

As the pioneering and longest-tenured meeting dedicated to optimizing and manipulating Treg-based approaches, this summit invites you to become part of a community at the forefront of innovation. Gain unparalleled insights into the latest developments driving specificity, delve into novel cell product design, and explore the engineering of CAR-Tregs to enhance cell stability and durability.

Don’t miss this unique opportunity to stay ahead in the dynamic landscape of Treg therapies. Join Beacon’s Immune Tolerance Research Analyst, Rachel Hourigan, for a look at the current Treg landscape for autoimmune diseases & recent deals and emerging companies, and contribute to the ongoing dialogue that shapes the future of cutting-edge medical advancements.

Find out more

6th Cell Engager Summit 2024

May 21 – 23, 2024 | Boston, MA

With a whopping 7 approvals in the last two years, the field is alive with positive clinical readouts and the drive to get more life-changing cell engager therapeutics to patients in indications of huge unmet need.

The timely 6th Cell Engager Therapeutics Summit is back once again to meet the needs of the community, focused on reaching new indications by expanding the target space and focusing our content on novel targets as well as continuing the push to focus on the translational challenges of developing cell engager therapies for solid and liquid tumors.

This is your one-stop shop for all of the must-have content dedicated to all engagers such as T-cell engagers, BiTe’s, gamma delta engagers and NK engages. Join Beacon and our expert Research Analyst, Flavio Lima Bianchi, as he maps out the past, present & future of cell engager therapies. Find out the full Day 2 opening presentation details here.

Find out more